Topic: Novo Nordisk

The Raw Egg Nationalist argues that traditional weight loss builds lasting habits, whereas drugs like Ozempic create a lifelong dependency on pharmaceutical companies. He criticizes "fat positivity" influencers for allegedly taking money from companies like Novo Nordisk to promote the idea that weight cannot be managed without medication. This is framed as a surrender of personal freedom to the medical-industrial complex.

Novo Nordisk, the manufacturer of Wegovy and Ozempic, has become the largest company in Europe, with a valuation exceeding the entire GDP of Denmark. The company is reportedly responsible for almost all economic growth in its home country. Despite this success, weight-loss drugs have only reached one-eighth of the potential American market, suggesting massive future growth.

Donald Trump holds a Rose Garden press conference announcing significant discounts on GLP-1 weight loss drugs through agreements with Eli Lilly and Novo Nordisk. Attendees include Robert F. Kennedy Jr., Howard Lutnick, and Mehmet Oz. Trump links the drug pricing negotiations to his broader tariff strategy, asserting that most-favored-nation status will finally be applied to American pharmaceutical consumers.

**category:** news_update | **confidence :** 9 | **ad:** false During a White House press conference regarding drug costs, Novo Nordisk executive Gordon Findlay collapses and is dragged out of the Oval Office. The host links the fainting spell to the alleged toxicity of Ozempic, which he claims is made from synthetic Gila monster and anglerfish venom. The incident is framed as "live-time karma" occurring just as the drug's safety was being discussed.

Marjorie Taylor Greene is shown confronting a British reporter over border security and media bias. Concurrently, RFK Jr. testifies against the use of Medicare funds for the weight-loss drug Ozempic, produced by the Danish company Novo Nordisk. Kennedy argues that the $3 trillion annual cost would be better spent on regenerative agriculture and gym memberships to address the root causes of obesity.

Gerald Celente criticizes the pharmaceutical industry for marketing obesity drugs to children under 12 instead of promoting healthy diets. He also discusses the failure of the Dodd-Frank Act to reform Wall Street, noting that the Federal Reserve recently capitulated to megabank demands to lower capital reserve requirements.